TNFSF11 and prostate carcinoma: Indeed, SDF1 has clearly been implicated in the mechanisms underlying the homing of metastatic cancer cells, including breast and prostate carcinomas, and RANKL is increasingly recognized as a crucial factor for cancer cell motility, in addition to its well-established role in tumor-induced osteolysis [23].